Article

Device offers good predictability of flap thickness

Paris-The Schwind microkeratome (Schwind Technologies) is a safe instrument and allows creation of flaps with predictable thickness, according to Ioannis Aslanides, MD, and Vinod Kumar, MD.

Paris-The Schwind microkeratome (Schwind Technologies) is a safe instrument and allows creation of flaps with predictable thickness, according to Ioannis Aslanides, MD, and Vinod Kumar, MD.

Dr. Aslanides is clinical director, refractive surgery and glaucoma, Vardinoyian-nion Eye Institute of Crete, Greece, and Dr. Kumar is presently a consultant ophthalmic surgeon, University Hospital of Wales, Cardiff, and the Princess of Wales Hospital, Bridgend, United Kingdom.

Dr. Aslanides reported that the flap thicknesses in the first and second eyes of each patient were a mean of 122.3 ±15.6 and 114.4 ±16.3 µm, respectively (average, 118.4 ±16.7 µm). The flap diameters were 9.55 ±0.37 and 9.51 ±0.36 mm, respectively (average, 9.53 ±0.37 mm) and the hinges were 4.56 ±0.55 and 4.54 ±0.48 mm, respectively (average, 4.55 ±0.52 mm).

There was no correlation between flap thickness and corneal thickness, K measurements, or refractive error. During the surgeries, there were three flap displacements. No visible interface debris was observed. Importantly, Dr. Aslanides noted that on the first day after the surgery the uncorrected visual acuity (UCVA) was 0.9 or better in 82% of eyes.

"Based on these results, we found the Schwind microkeratome to be safe and to provide excellent interface clarity and good predictability for flap thickness. In addition, multiple use of the blade results in a thinner flap," Dr. Aslanides stated.

Sixty-two patients with myopia were included in this study. The mean patient age was 33 years (range, 20 to 52 years). In the eyes treated with the Schwind microkeratome, the preoperative spherical error was 5.69 ±2.60 D and in the eyes treated with the Moria M2 microkeratome, the mean spherical error was 5.67 ±2.22 D.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.